Sort   by:  
 Page size 
UnknownHeterogeneity of genetic modifiers ensures normal cardiac development.
Not available
S-EPMC2953850 | biostudies-literature
UnknownUsing electronic health record collected clinical variables to predict medical intensive care unit mortality.
Not available
S-EPMC5037117 | biostudies-literature
UnknownAntibiotics prior to age 2 years have limited association with preschool growth trajectory.
Not available
S-EPMC8967797 | biostudies-literature
UnknownEarly Antibiotic Exposure and Weight Outcomes in Young Children.
Not available
S-EPMC6317759 | biostudies-literature
UnknownPCORnet Antibiotics and Childhood Growth Study: Process for Cohort Creation and Cohort Description.
Not available
S-EPMC9746871 | biostudies-literature
UnknownDietary metabolic signatures and cardiometabolic risk.
Not available
S-EPMC10169425 | biostudies-literature
UnknownInterventions to improve system-level coproduction in the Cystic Fibrosis Learning Network.
Not available
S-EPMC11287073 | biostudies-literature
UnknownMacular Morphology and Visual Acuity in the Second Year of the Comparison of Age-Related Macular Degeneration Treatments Trials.
Not available
S-EPMC4998967 | biostudies-literature
UnknownIntraocular Pressure-Related Events After Anti-Vascular Endothelial Growth Factor Therapy for Macular Edema Due to Central Retinal Vein Occlusion or Hemiretinal Vein Occlusion: SCORE2 Report 16 on a Secondary Analysis of a Randomized Clinical Trial.
Not available
S-EPMC8554687 | biostudies-literature
UnknownBaseline Characteristics and Outcomes After Anti-Vascular Endothelial Growth Factor Therapy for Macular Edema in Participants With Hemiretinal Vein Occlusion Compared With Participants With Central Retinal Vein Occlusion: Study of Comparative Treatments for Retinal Vein Occlusion 2 (SCORE2) Report 18.
Not available
S-EPMC8949717 | biostudies-literature
Sort   by:  
 Page size